Your Guide to Cancer Statistics
Surveillance Epidemiology and End Result Program
-
Overview of the SEER Program
The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) is an authoritative source of information on cancer incidence and survival in the United States.
-
SEER Fast Facts
An interactive website for SEER cancer statistics by Sex, Delay-adjusted SEER Incidence Rate, All Races/Ethnicities, and Age.
-
SEER-Medicare
The SEER-Medicare data reflect the linkage of two large population-based sources of data that provide detailed information about Medicare beneficiaries with cancer.
Other Federal & State Cancer Data
-
National Cancer Institute
Improving the lives of all people through cancer research. NCI is the nation’s trusted source for cancer information. We are here for you with information about causes and risk factors, symptoms, how cancer is diagnosed, and treatment options.
-
NCI's Cancer Information Service
NCI's Cancer Information Service (CIS) can help answer your cancer-related questions whether you are a patient, family or friend, health care provider, or researcher.
-
State Cancer Profiles
State Cancer Profiles is an interactive map engine produced in collaboration between the National Cancer Institute and Centers for Disease Control and Prevention.
-
Cancer Mortality Maps
Dynamic views of cancer statistics for prioritizing cancer control efforts across the nation.
North American Association of Central Cancer Registries
-
NAACCR Fast Stats
NAACCR provides a number of interactive on-line data tools for quick access to cancer statistics in US and Canada.
-
NAACCR Quick Cancer Stats and Maps
NAACCR is an interactive map that reflects Invasive Cancer Incidence Rates in North America by state/providence.
Reports
-
SEER Cancer Stat Fact Sheets
Cancer Stat Facts are a collection of statistical summaries for a number of common cancer types. They were developed to provide a quick overview of frequently-requested cancer statistics.
-
SEER Cancer Statistics Review (CSR)
The Surveillance, Epidemiology, and End Results (SEER) Program, provides cancer statistics in the US, collecting data from population-based cancer registries covering approximately 48% of the US population, providing information on incidence, mortality, survival, and prevalence. See the annual report here.
Additional Resources
-
Arab-American Naming Algorithm Data
Publications using Arab-American data to provide valuable insights into cancer trends, treatment, and research.
-
Michigan Cancer Surveillance Program
In 2022, the North American Association of Central Cancer Registries (NAACCR) awarded Gold Certification to the Michigan Cancer Surveillance Program for quality, completeness, and timeliness of 2019 cancer data.
-
MDCSS Publication List
Publications using MDCSS data to provide valuable insights into cancer trends, treatment, and research.
Glossary
Age-adjusted rate
A weighted average of the age-specific cancer incidence or mortality rates. The weights are the proportions of the persons broken down into age groups of a standard population. The 2000 U.S. standard million population is used to weight the age-adjusted rates for incidence and mortality.
Incidence rate
The number of new cancers, at a specific site or all sites combined, occurring in a population during one year, expressed as the number per 100,000 people. Please note, this can include multiple primary cancers occurring in one individual.
Mortality rate
The number of deaths with cancer given as the underlying cause of death occurring during one year, expressed as the number per 100,000 people.
Relative Survival rate
The ratio of the observed survival rate in the cancer population to the expected survival rate for a non-cancer population. The relative survival takes into account the possibility of death from causes other than cancer and allows for comparisons of survival between populations. Individuals identified only by death certificate or autopsy are excluded, as are individuals still alive but with no follow-up after the date of diagnosis. Also, a true survival rate can not be computed if the total diagnoses are 25 or fewer, or if all cases become lost to follow-up.
SEER
The National Cancer Institute's Surveillance, Epidemiology, and End Results Program.
Stage of Disease at Diagnosis
Local - an invasive neoplasm confined to the organ of origin.
Regional - an invasive neoplasm which spreads from the organ of origin to surrounding organs or tissues, and/or regional lymph nodes.
Distant - an invasive neoplasm which spreads to distant parts of the body from the organ of origin through direct extension or discontinuous metastasis.
Staging at Diagnosis
Limited to two months after diagnosis.